Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Post-Market Trading 03-26 16:54:23 EDT

34.67

-0.38

-1.08%

盘后34.67

+0.000.00%

16:05 EDT

High35.03	Low34.00	Vol1.09M
Open34.75	D1 Closing35.05	Amplitude2.94%
Mkt Cap6.37B	Tradable Cap2.81B	Total Shares183.65M
T/O37.58M	T/O Rate1.35%	Tradable Shares80.99M
P/B6.12	ROE-15.45%	EPS-0.97
52wk High60.87	52wk Low30.17	P/E-35.81
Dividend0.00	Div.Yield0.00	ROA-10.84%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":34.67,"timestamp":1743019200000,"preClose":35.05,"halted":0,"volume":1090996,"hourTrading":{"tag":"盘后","latestPrice":34.67,"preClose":34.67,"latestTime":"16:05 EDT","volume":14567,"amount":505044.47428399994,"timestamp":1743019513249},"delay":0,"floatShares":80994144,"shares":183649157,"eps":-0.968143,"marketStatus":"Post-Market Trading","change":-0.38,"latestTime":"03-26 16:54:21 EDT","open":34.75,"high":35.03,"low":34,"amount":37577763.488639,"amplitude":0.029387,"askPrice":35,"askSize":5,"bidPrice":34,"bidSize":28,"shortable":3,"etf":0,"ttmEps":-0.968143,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743033600000},"marketStatusCode":4,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":35.05,"preHourTrading":{"tag":"盘前","latestPrice":34.98,"preClose":35.05,"latestTime":"09:28 EDT","volume":120,"amount":4199.19984,"timestamp":1742995680076},"postHourTrading":{"tag":"盘后","latestPrice":34.67,"preClose":34.67,"latestTime":"16:05 EDT","volume":14567,"amount":505044.47428399994,"timestamp":1743019513249},"volumeRatio":1.12783,"impliedVol":0.6636,"impliedVolPercentile":0.672},"requestUrl":"/m/hq/s/LEGN/tweets","defaultTab":"tweets","newsList":[{"id":"2520570667","title":"Legend Biotech Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2520570667","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520570667?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 00:55","pubTimestamp":1742230500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 12:55 ET (16:55 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2520517261","title":"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and EyePoint Pharmaceuticals (EYPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520517261","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520517261?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 17:50","pubTimestamp":1742205032,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Legend Biotech (LEGN – Research Report) and EyePoint...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-eyepoint-pharmaceuticals-eypt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-eyepoint-pharmaceuticals-eypt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","LEGN","BK4007","BK4585","BK4505","LU0320765992.SGD","HCSG","LU0109394709.USD","BK4139","EYPT","LU0889565916.HKD"],"gpt_icon":0},{"id":"2519744310","title":"Legend Biotech (LEGN) Blockbuster Fuels Expectation-beating Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2519744310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519744310?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 13:16","pubTimestamp":1741842988,"startTime":"0","endTime":"0","summary":"Legend Biotech’s ($LEGN) shares have surged over 10% in the past few days, spurred by the company’s latest earnings report, thanks to expectation-b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/legend-biotech-legn-blockbuster-fuels-expectation-beating-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/legend-biotech-legn-blockbuster-fuels-expectation-beating-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LEGN","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2518906523","title":"William Blair Sticks to Their Hold Rating for Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518906523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518906523?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 16:46","pubTimestamp":1741769161,"startTime":"0","endTime":"0","summary":"William Blair analyst Sami Corwin maintained a Hold rating on Legend Biotech (LEGN – Research Report) today. The company’s shares closed yesterday ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-hold-rating-for-legend-biotech-legn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-hold-rating-for-legend-biotech-legn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN"],"gpt_icon":0},{"id":"2518056224","title":"Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2518056224","media":"GuruFocus.com","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518056224?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 15:02","pubTimestamp":1741762956,"startTime":"0","endTime":"0","summary":"Net Trade Sales of CARVYKTI: $334 million in Q4 2024, a 110% increase year-over-year and a 17% increase from Q3.OUS Sales: $31 million, a 138% increase year-over-year and 15% quarter-over-quarter.Net Profit: $26 million or $0.07 per share for Q4 2024.Collaboration Cost of Revenue: $69 million for Q4 2024, up from $32 million in the same period last year.Research and Development Expenses: $104 million for Q4 2024, compared to $106 million in the same period last year.Administrative Expenses: $34 million for Q4 2024, up from $29 million in the same period last year.Selling and Distribution Expenses: $49 million for Q4 2024, up from $34 million in the same period last year.Adjusted Net Loss: $59 million or $0.16 per share for Q4 2024.Cash and Equivalents: $1.1 billion at the end of 2024.GuruFocus has detected 3 Warning Signs with LEGN.Legend Biotech Corp  reported a 110% year-over-year increase in net trade sales of CARVYKTI, reaching approximately $334 million in the fourth quarter of 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/legend-biotech-corp-legn-q4-070236950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LEGN"],"gpt_icon":0},{"id":"2518032380","title":"Q4 2024 Legend Biotech Corp Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2518032380","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518032380?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 13:34","pubTimestamp":1741757647,"startTime":"0","endTime":"0","summary":"Caroline Paul; Associate Director of Investor Relations; Nanjing Legend Biotechnology Co Ltd. Ying Huang; Chief Executive Officer; Nanjing Legend Biotechnology Co Ltd. Jessie Yeung; Interim Chief Financial Officer; Nanjing Legend Biotechnology Co Ltd. Alan Bash; President of CARVYKTI; Nanjing Legend Biotechnology Co Ltd. Guowei Fang; Chief Scientific Officer, Head - Business Development; Nanjing Legend Biotechnology Co Ltd. Mitchell Kapoor; Analyst; H.C. Wainwright & Co., LLC. Good day, and welcome to the Legend Biotech fourth quarter and full year 2024 earnings call.  As a reminder, this call may be recorded. I would now like to turn the call over to Caroline Paul, Associate Director of Investor Relations. Please go ahead.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-legend-biotech-corp-053407035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LEGN","NVS"],"gpt_icon":0},{"id":"2518720128","title":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720128?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 01:57","pubTimestamp":1741715875,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, DisneyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4N3PU10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWCZ","HTZ","AAL","CAR","EXPE","RAY","STLD","BK4211","LU2362540622.SGD","BCRX","BK4534","LU2063271972.USD","NFE","TSYW.SI","WCT","LU0320765489.SGD","LU0106261372.USD","LU0957791311.USD","MASS","AMAL","CENX","ALKT","LZMH","UAL","WYNN","LU2237957811.SGD","LFMD","SYRS","LEGN","MLYS","BLZE","LU1983299246.USD","ILMN","LU0053671581.USD","RELY","HUT","NVAX","TER","LYFT","SEZL","BVS","ARVN","COEP","TSVT","LU0058720904.USD","ELV"],"gpt_icon":1},{"id":"2518725750","title":"Genscript Biotech Announces Legend Biotech’s 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518725750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518725750?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 23:16","pubTimestamp":1741706169,"startTime":"0","endTime":"0","summary":"Genscript Biotech ( ($HK:1548) ) has provided an update. Genscript Biotech Corporation announced the financial results of its associate, Legend Bio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genscript-biotech-announces-legend-biotechs-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genscript-biotech-announces-legend-biotechs-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","BK4588","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2518740701","title":"BUZZ-Legend Biotech gains on narrower Q4 loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740701?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 22:00","pubTimestamp":1741701633,"startTime":"0","endTime":"0","summary":"BUZZ-Legend Biotech gains on narrower Q4 loss** Cancer therapy maker Legend Biotech's LEGN.O shares rise 5.6% to $35.96** Co posts Q4 adj. net loss of 16 cents per share, compared to a loss of 24 cents per share a year earlier** Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which co believes will provide financial runway into Q2 2026** LEGN has fallen 46.1% in the past 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4N3PU0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","01548","HK0000320223.HKD","BK4505","BK1576","LEGN","HK0000320264.USD","BK1141","BK4588","BK4585","HK0000306701.USD","BK1583","HK0000306685.HKD"],"gpt_icon":0},{"id":"2518234247","title":"Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2518234247","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518234247?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:30","pubTimestamp":1741699806,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation Sponsored ADR  reported $186.52 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 134.7%. EPS of -$0.15 for the same period compares to -$0.40 a year ago.The reported revenue represents a surprise of +3.32% over the Zacks Consensus Estimate of $180.53 million. With the consensus EPS estimate being -$0.39, the EPS surprise was +61.54%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Legend Biotech performed in the just reported quarter in terms of the metrics most widely monitored a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compared-estimates-legend-biotech-legn-133006114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LEGN"],"gpt_icon":0},{"id":"2518749247","title":"Sector Update: Health Care Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2518749247","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518749247?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:15","pubTimestamp":1741698935,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Tuesday with the iShares Biotechnology ETF  down 0.1% and the Health Care Select Sector SPDR Fund  recently up 0.1%.Arvinas  and Pfizer  said a phase 3 clinical trial of vepdegestrant monotherapy as an investigational treatment for advanced or metastatic breast cancer met its primary endpoint in the estrogen receptor 1-mutant population, but did not reach statistical significance in progression-free survival improvement in the intent-to-treat population. Arvinas shares fell by more than 37% pre-bell.Legend Biotech  shares were up more than 1% after the company reported a narrowed Q4 adjusted net loss as revenue increased during the period.Illumina  shares rose past 2% after the company announced a $100 million cost reduction program, while lowering its fiscal 2025 non-GAAP earnings forecast.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU0306806265.USD","LU0234572021.USD","SG9999001176.USD","BK4599","LU1066053197.SGD","XLV","BK4007","LU0225771236.USD","IE00B19Z3B42.SGD","IBB","BK4592","BK4535","LU1894683264.USD","LU0868494617.USD","IE00BLSP4239.USD","LU0289739699.SGD","PFE","BK4548","BK4121","BK4581","ARVN","LU0058720904.USD","LU0321505439.SGD","SG9999003800.SGD","LU1894683348.USD","PFE.AU","BK4585","BK4534","LU1883839398.USD","LEGN","LU1057294990.SGD","ILMN","LU0306807586.USD","LU1066051498.USD","SG9999002224.SGD","IE00B19Z3581.USD","SG9999013999.USD","BK4568","SG9999001176.SGD","BK4533","LU0456855351.SGD","BK4505","LU0170899867.USD","LU0225284248.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4588","BK4550","LU1023059063.AUD"],"gpt_icon":1},{"id":"2518712423","title":"Legend Biotech's Q4 Net Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2518712423","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518712423?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 19:16","pubTimestamp":1741691765,"startTime":"0","endTime":"0","summary":"Legend Biotech  reported Tuesday a Q4 adjusted net loss of $0.15 per diluted share, narrower than its loss of $0.24 per share a year earlier.Analysts polled by FactSet expected a loss of $0.25.Revenue for the quarter ended Dec. 31 was $186.5 million, up from $79.5 million a year earlier.Analysts surveyed by FactSet expected $178.1 million.As of Dec. 31, the company said it had approximately $1.1 billion of cash and cash equivalents and time deposits, and expected it could fund operations through Q2 of fiscal 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN"],"gpt_icon":0},{"id":"2518712871","title":"Legend Biotech Q4 2024 Adj EPS $(0.16) Beats $(0.33) Estimate, Sales $186.52M Beat $178.93M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518712871","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518712871?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 19:07","pubTimestamp":1741691223,"startTime":"0","endTime":"0","summary":"Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.33) by 51.52 percent. This is a 33.33 percent increase over losses of $(0.24) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44242947/legend-biotech-q4-2024-adj-eps-0-16-beats-0-33-estimate-sales-186-52m-beat-178-93m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Legend Biotech Q4 2024 Adj EPS $(0.16) Beats $(0.33) Estimate, Sales $186.52M Beat $178.93M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2518123877","title":"Earnings Flash (LEGN) Legend Biotech Posts Q4 EPS $0.07 a Share, vs. FactSet Est of $-0.23 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2518123877","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518123877?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 19:07","pubTimestamp":1741691223,"startTime":"0","endTime":"0","summary":"Earnings Flash (LEGN) Legend Biotech Posts Q4 EPS $0.07 a Share, vs. FactSet Est of $-0.23 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN"],"gpt_icon":0},{"id":"2518128467","title":"Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2518128467","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518128467?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 19:00","pubTimestamp":1741690800,"startTime":"0","endTime":"0","summary":"CARVYKTI net trade sales of approximately $334 million and $963 million for the fourth quarter and full year 2024, respectivelyOver 5,000 patients treated to dateInitiated commercial production of CAR","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040406/0/en/Legend-Biotech-Reports-Fourth-Quarter-and-Full-Year-2024-Results-and-Recent-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","BK4139","BK4585","BK4505","BK4588"],"gpt_icon":0},{"id":"2518471593","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471593?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:00","pubTimestamp":1741687200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Allbirds Inc. Class A                           4Q       4:05 PM. ·Dick's Sporting Gds                              4Q      3.52   7:00 AM. ·E. W. Scripps Co                                 4Q      1.01       AMC. ·European Wax Ctr                                4Q       .06   6:00 AM. ·First Watch Rest                                4Q       .01   7:00 AM. ·Kanzhun Ltd. Sp ADR                               4Q       .22       BMO","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BW","ACHV","KALV","MNTK","MGTX","ONDS","APYX","SID","TH","LEGN","RMBL","BBCP","S","ZYXI","SKYX","SPRB","UNFI","KSS","NOA","AKBA","AFCG","EBR","FTCI","SSP","KFY","BIRD","ABM","BTMD","WEST","BZ","ASRT","HLLY","ARCO","PHLT","DRUG","KRMD","WSM","AGEN","ATLC","EWCZ","BLDE","SKIN","LRMR","BWAY","SMSI","EXK","VTS","DKS","QRHC"],"gpt_icon":1},{"id":"2517480254","title":"Legend Biotech Corp  expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480254?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 21:16","pubTimestamp":1741353373,"startTime":"0","endTime":"0","summary":"Legend Biotech Corp  expected to post a loss of33cents a share - Earnings Preview Legend Biotech Corp LEGN.OQ LEGN.O is expected to show a rise in quarterly revenue when it reports  results on March 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","01548"],"gpt_icon":0},{"id":"2514099867","title":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099867","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099867?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 21:00","pubTimestamp":1740488400,"startTime":"0","endTime":"0","summary":"SOMERSET, N.J., Feb. 25, 2025  -- Legend Biotech Corporation  , a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quarter and full-year 2024 results.During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s quarter and fiscal year performance.Investors and other interested parties may join the live audio webcast of the call via this weblink.A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentation section approximately two hours after the call concludes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/legend-biotech-host-investor-conference-130000020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4218","BK4505","HST","LEGN","BK4588","BK4585","BK4181"],"gpt_icon":1},{"id":"2513547657","title":"Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2513547657","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513547657?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 02:29","pubTimestamp":1740335385,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where Legend Biotech Corporation  stands against the other oversold pharma stocks to buy according to analysts.On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity drugs. She believed the industry may not underperform this year, at least in the first half. However, there are still several questions surrounding the performance of obesity drugs, as major players in the domain have exhibited contrasting previous year performance.Angelica Peebles, CNBC’s Health and Pharma reporter, sat with Eli Lilly’s Chief Scientific Officer to talk about the weight loss sector. From the conversation, she reported that the domain poses opportunity for drugs that are easier to use, such as pills, and medicines that make ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-legend-biotech-corporation-legn-182945918.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","TQQQ","PSQ","SQQQ",".IXIC","QID","TSYW.SI","BK4505","BK4139","NVIW.SI","BK4585","NQmain","USAW.SI","BK4588","QLD","LEGN","USJW.SI"],"gpt_icon":1},{"id":"2513296550","title":"Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296550","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513296550?lang=en_us&edition=full_marsco","pubTime":"2025-02-21 22:43","pubTimestamp":1740149016,"startTime":"0","endTime":"0","summary":"Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. During the quarter, the significant market influences were the U.S. election results, inflation, and the direction of interest rates. Against this backdrop, the fund returned 1.70%  during the quarter outperforming the 0.62% returns of the Russell 2500 Index and -0.26% returns of the secondary benchmark the Russell 2500 Value Index. In addition, please check the fund’s top five holdings to know its best picks in 2024.Meridian Contrarian Fund stated the following regarding Legend Biotech Corporation  in its Q4 2024 investor letter:. Inanother article we discussed Legend Biotech Corporation  and shared the list of best mid-cap growth stocks to buy according to analysts. In addition, please che","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/market-concerns-put-pressure-legend-144336729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","QID","MNQmain","BK4585","BK4588","USAW.SI","BK4505","SQQQ","LEGN","TSYW.SI","BK4139","PSQ","USJW.SI","NVIW.SI","TQQQ","QLD","NQmain"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0747},{"period":"1month","weight":-0.1171},{"period":"3month","weight":0.0686},{"period":"6month","weight":-0.2519},{"period":"1year","weight":-0.3814},{"period":"ytd","weight":0.0771}],"compareEarnings":[{"period":"1week","weight":0.0257},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.043},{"period":"6month","weight":0.0055},{"period":"1year","weight":0.1071},{"period":"ytd","weight":-0.0181}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.018049},{"month":2,"riseRate":0.4,"avgChangeRate":0.004169},{"month":3,"riseRate":0.6,"avgChangeRate":-0.021654},{"month":4,"riseRate":0.75,"avgChangeRate":0.086701},{"month":5,"riseRate":0.5,"avgChangeRate":0.05248},{"month":6,"riseRate":1,"avgChangeRate":0.131481},{"month":7,"riseRate":0.6,"avgChangeRate":0.020473},{"month":8,"riseRate":0.2,"avgChangeRate":-0.044443},{"month":9,"riseRate":0.2,"avgChangeRate":-0.015767},{"month":10,"riseRate":0.4,"avgChangeRate":0.000994},{"month":11,"riseRate":0.4,"avgChangeRate":0.003857},{"month":12,"riseRate":0,"avgChangeRate":-0.083204}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}